Müllner K - Search Results

1

[A peculiar pancreatic lesion: nodular foci of trilineage differentiation and diffuse islet cell hyperplasia].

Zalatnai A, Tőke J, Huszty G, Müllner K, Tóth M. Zalatnai A, et al. Among authors: mullner k. Orv Hetil. 2021 Feb 7;162(6):227-232. doi: 10.1556/650.2021.31989. Orv Hetil. 2021. PMID: 33550275 Hungarian.

2

[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].

Mullner K, Molnar B, Tulassay Z. Mullner K, et al. Orv Hetil. 2007 Mar 25;148(12):543-51. doi: 10.1556/OH.2007.27902. Orv Hetil. 2007. PMID: 17444020 Review. Hungarian.

3

[Sedation and analgesia during gastrointestinal endoscopy].

Müllner K, Tulassay Z. Müllner K, et al. Orv Hetil. 2011 Mar 13;152(11):428-36. doi: 10.1556/OH.2011.29063. Orv Hetil. 2011. PMID: 21362603 Hungarian.

4

Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy.

Igaz P, Müllner K, Hargitai B, Igaz I, Tömböl Z, Rácz K, Tulassay Z. Igaz P, et al. Among authors: mullner k. Clin Endocrinol (Oxf). 2007 Nov;67(5):805-6. doi: 10.1111/j.1365-2265.2007.02957.x. Epub 2007 Jul 3. Clin Endocrinol (Oxf). 2007. PMID: 17608816 No abstract available.

5

Low bone mass in microscopic colitis.

Lorinczy K, Lakatos G, Müllner K, Hritz I, Lakatos PL, Tulassay Z, Miheller P. Lorinczy K, et al. Among authors: mullner k. BMC Gastroenterol. 2011 May 19;11:58. doi: 10.1186/1471-230X-11-58. BMC Gastroenterol. 2011. PMID: 21595910 Free PMC article.

6

Update on the pharmacogenomics of proton pump inhibitors.

Hagymási K, Müllner K, Herszényi L, Tulassay Z. Hagymási K, et al. Among authors: mullner k. Pharmacogenomics. 2011 Jun;12(6):873-88. doi: 10.2217/pgs.11.4. Pharmacogenomics. 2011. PMID: 21692617 Review.

7

Probiotics in the management of Crohn's disease and ulcerative colitis.

Müllner K, Miheller P, Herszényi L, Tulassay Z. Müllner K, et al. Curr Pharm Des. 2014;20(28):4556-60. doi: 10.2174/13816128113196660727. Curr Pharm Des. 2014. PMID: 24180407 Review.

8

Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?

Miheller P, Mandel MD, Mullner K, Lakatos PL. Miheller P, et al. Among authors: mullner k. Expert Rev Clin Immunol. 2013 Sep;9(9):871-82. doi: 10.1586/1744666X.2013.824675. Expert Rev Clin Immunol. 2013. PMID: 24070050 Review.

9

Have biologics changed the natural history of Crohn's disease?

Mandel MD, Miheller P, Müllner K, Golovics PA, Lakatos PL. Mandel MD, et al. Among authors: mullner k. Dig Dis. 2014;32(4):351-9. doi: 10.1159/000358135. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969279 Review.

10

Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.

Bor R, Fábián A, Matuz M, Szepes Z, Farkas K, Miheller P, Szamosi T, Vincze Á, Rutka M, Szántó K, Bálint A, Nagy F, Milassin Á, Tóth T, Zsigmond F, Bajor J, Müllner K, Lakner L, Papp M, Salamon Á, Horváth G, Sarang K, Schäfer E, Sarlós P, Palatka K, Molnár T. Bor R, et al. Among authors: mullner k. Expert Opin Biol Ther. 2020 Feb;20(2):205-213. doi: 10.1080/14712598.2020.1699529. Epub 2019 Dec 6. Expert Opin Biol Ther. 2020. PMID: 31782939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page